Acetylcholine but not sodium nitroprusside exerts vasodilation in pulmonary hypertension secondary to chronic congestive heart failure

Journal of Heart and Lung Transplantation

Volumn 18, Issue 9, 1999, Pages 877-883

  Wensel, Roland ^a   Opitz, Christian F ^a   Kleber, Franz X ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL TONE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HEMODYNAMICS; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; CHRONIC DISEASE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; NITROPRUSSIDE; PULMONARY ARTERY; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0032836996     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00041-8     Document Type: Article

References (30)

1. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 19:1992;918-925.
2. Drexler H., Hayoz D., Münzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 69:1992;1596-1601.
3. Nakamura M., Ishikawa M., Funakoshi T., Hashimoto K., Chiba M., Hiramori K. Attenuated endothelium-dependent peripheral vasodilation and clinical characteristics in patients with chronic heart failure. Am Heart J. 128:1994;1164-1169.
4. Di Salvo T.G., Mathier M., Semigran M.J., Dec G.W. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 25:1995;1143-1153.
5. Kirklin J.K., Naftel D.C., Kirklin J.W., Blackstone E.H., White-Williams C., Bourge R.C. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 7:1988;331-336.
6. Myers J., Salleh A., Buchanan N., et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J. 124:1992;710-719.
7. Kleber F.X., Reindl I., Wernecke K.D., Baumann G. Dyspnea in heart failure. Wasserman K. Exercise Gas Exchange in Heart Disease. 1995;95-107 Futura Publishing Company, Inc, Armonk, NY.
8. Cremona G., Dinh Xuan A.T., Higenbottam T.W. Endothelium-derived relaxing factor and the pulmonary circulation. Lung. 169:1991;185-202.
9. Stamler J.S., Loh E., Roddy M.-A., Currie K.E., Creager M.A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 89:1994;2035-2040.
10. Cooper C.J., Landzberg M.J., Anderson T.J., et al. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation. 93:1996;266-271.
11. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
12. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
13. Feddersen C.O., Mathias M.M., McMurtry I.F., Voelkel N.F. Acetylcholine induces vasodilation and prostacyclin synthesis in rat lung. Prostaglandins. 31:1986;973-987.
14. Vanhoutte P.M. Other endothelium-derived vasoactive factors. Circulation. 87:(suppl V):1993;V-9-V-17.
15. Campbell W.B., Gebremedhin D., Pratt P.F., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolaryzing factors. Circ Res. 78:1996;415-423.
16. Celermeier D.S., Cullen S., Deanfield J.E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 87:1993;440-446.
17. Celermeier D.S., Dollery C., Burch M., Deanfield J.E. Role of endothelium in the maintainance of low pulmonary vascular tone in normal children. Circulation. 89:1994;2041-2044.
18. Kleber F.X., Wensel R., Felix S.B., Reindl I., Baumann G. Acetylcholine causes dose dependent increase in pulmonary flow in patients with chronic heart failure and elevated pulmonary vascular resistance. Basic Res Cardiol. 91:1996;401-405.
19. Porter T.R., Taylor D.O., Cycan A., et al. Endothelium-dependent pulmonary artery responses in chronic heart failure Influence of PHT . J Am Coll Cardiol. 22:1993;1418-1424.
20. Harris P. Influence of acetylcholine on the pulmonary arterial pressure. Br Heart J. 19:1957;272.
21. Wessel D.L., Adatia I., Giglia T.M., Thompson J.E., Kulik T.J. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 88:1993;2128-2138.
22. Dinh Xuan A.T., Higenbottam T.W., Clelland C., Pepke-Zaba J., Cremona G., Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol. 99:1989;9-10.
23. Costard-Jäckle A., Fowler M.B. Influence of preoperative PAP on mortality after heart transplantation Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group . J Am Coll Cardiol. 19:1992;48-53.
24. Borges A.C., Wensel R., Opitz C., Bauer U., Baumann G., Kleber F.X. Relationship between haemodynamics and morphology in pulmonary hypertension. A quantitative intravascular ultrasound study. Eur Heart J. 18:1997;1988-1994.
25. Conger J., Robinette J., Villar A., Raij L., Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest. 96:1995;631-638.
26. Yanagisawa M., Kurihara H., Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
27. Cody R.J., Haas G.J., Binkley PhF, Capers Qu, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 85:1992;504-509.
28. Stewart D.J. Endothelial dysfunction in pulmonary vascular disorders. Arzneim-forsch. 44:1994;3a.
29. Giaid A., Yanagisawa M., Langleben D. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 328:1993;1732-1739.
30. Christman B.W., McPherson C.D., Newman J.H., et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 327:1992;70-75.